VITRISA THERAPEUTICS
Vitrisa Therapeutics is a privately held, preclinical stage, biotech company headquartered in the San Francisco Bay Area.
VITRISA THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Therapeutics
Founded:
2020-01-03
Address:
Larkspur, California, United States
Country:
United States
Website Url:
http://www.vitrisatherapeutics.com
Total Employee:
1+
Status:
Closed
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF Mobile Non Scaleable Content Google Adsense AdBlock Acceptable Ads Google Adsense For Domains
Similar Organizations
Alba Therapeutics
Alba Therapeutics Corporation is a privately held, clinical-stage biopharmaceutical Company.
Artery Therapeutics Inc.
Artery Therapeutics Inc. is a biotechnology company headquartered in the San Francisco Bay area
Akashi Therapeutics
Akashi Therapeutics is a clinical stage biopharmaceutical company.
Nivalis Therapeutics
Nivalis Therapeutics is a clinical-stage pharmaceutical company developing a novel class of disease modifying therapies.
Current Employees Featured
Official Site Inspections
http://www.vitrisatherapeutics.com
- Host name: 77.247.183.149
- IP address: 77.247.183.149
- Location: Netherlands
- Latitude: 52.3824
- Longitude: 4.8995
- Timezone: Europe/Amsterdam
More informations about "Vitrisa Therapeutics"
Vitrisa Therapeutics - LinkedIn
Our goal is to bring therapeutics that preserve or restore vision to people suffering from sight threatening ocular diseases - with an initial emphasis on orphan and rare pediatric ocular...See details»
Vitrisa Therapeutics Company Profile 2024: Valuation, Funding ...
Information on valuation, funding, cap tables, investors, and executives for Vitrisa Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Vitrisa Therapeutics - Crunchbase Company Profile & Funding
Vitrisa Therapeutics is a privately held, preclinical stage, biotech company headquartered in the San Francisco Bay Area.See details»
Vitrisa Therapeutics - Craft
Vitrisa Therapeutics is a biotech company focused on a proprietary suite of technologies for the discovery and development of optimized ocular therapeutics. Its mission is to functionally end …See details»
Vitrisa Therapeutics, Inc.: Drug pipelines, Patents, Clinical trials ...
Jun 13, 2023 · Explore Vitrisa Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 1 news.See details»
Vitrisa Therapeutics - Overview, News & Similar companies
View Vitrisa Therapeutics (www.vitrisatherapeutics.com) location in California, United States , revenue, industry and description. Find related and similar companies as well as employees …See details»
Vitrisa - Company Profile - Tracxn
Nov 1, 2024 · Vitrisa is a funded company. Who are Vitrisa's investors? Vitrisa has 3 institutional investors including Lightspeed Venture Partners, Design Technologies and Carmanah …See details»
Vitrisa Therapeutics - Contacts, Employees, Board Members, …
Vitrisa Therapeutics has 1 current employee profile, Head of CMC James McArdle. Vitrisa Therapeutics is a privately held, preclinical stage, biotech company headquartered in the San …See details»
Foundation Fighting Blindness and Vitrisa Therapeutics ... - BioSpace
Apr 27, 2018 · FFB-CRI was established in 2004 to advance translational research and clinical development of emerging therapies for inherited retinal diseases. Vitrisa Therapeutics, Inc. is a …See details»
Vitrisa-Therapeutics - Overview, Competitors, and Employees
View Vitrisa-Therapeutics revenue, competitors and contact information. Find and reach Vitrisa-Therapeutics' employees by department, seniority, title, and much more.See details»
Vitrisa Therapeutics Inc. - BioCentury Company Profiles - BCIQ
Jan 10, 2023 · Vitrisa Therapeutics Inc. - BioCentury Company Profiles for the biopharma industrySee details»
Vitrisa Therapeutics Acquires Rights to MAKO Clinical Trial Data in ...
May 16, 2018 · Under the terms of the newly announced deal, Vitrisa will initially receive non-exclusive rights to the data and a time-limited option to acquire worldwide exclusive ownership …See details»
Foundation Fighting Blindness and Vitrisa Therapeutics …
Apr 27, 2018 · Vitrisa Therapeutics, Inc. is a privately held and venture-backed biotechnology company based in the San Francisco Bay Area. Vitrisa is focused on developing a suite of …See details»
What is Vitrisa Therapeutics? Company Culture, Mission, Values
See what employees say it's like to work at Vitrisa Therapeutics. Salaries, reviews, and more - all posted by employees working at Vitrisa Therapeutics.See details»
Vitrisa Therapeutics - VentureRadar
Website: http://www.vitrisatherapeutics.com. Develops innovative therapeutics targeting vision-threatening ocular diseases, aiming to address unmet medical needs and improve patients' …See details»
Research programme: ocular disorder therapeutics - Vitrisa …
Vitrisa Therapeutics is developing therapeutics using its platform technologies, for the treatment of sight threatening ocular diseases, including StargardtSee details»
Working at Vitrisa Therapeutics - Glassdoor
See what employees say it's like to work at Vitrisa Therapeutics. Salaries, reviews, and more - all posted by employees working at Vitrisa Therapeutics.See details»
Vitrisa Therapeutics Acquires Rights to MAKO Clinical Trial Data in ...
May 16, 2018 · Under the terms of the newly announced deal, Vitrisa will initially receive non-exclusive rights to the data and a time-limited option to acquire worldwide exclusive ownership …See details»
Anti-VEGF-A aptamer (Vitrisa Therapeutics) - Drug Targets
RO-104 is a first-in-class modular tri-specific biologic curated to target all three dominant angiogenic pathways implicated in exudative retinal diseases.See details»
Anti-IL-8 aptamers (Vitrisa Therapeutics) - Drug Targets, …
Anti-IL-8 aptamers (Vitrisa Therapeutics): a IL-8 inhibitors Drug, Initially developed by Vitrisa Therapeutics, Inc., Now, its global highest R&D status is Pending, Mechanism: IL-8 inhibitors …See details»